Positive News SentimentPositive NewsNASDAQ:DMAA Drugs Made In America Acquisition (DMAA) Stock Price, News & Analysis $10.90 +0.01 (+0.05%) As of 11:37 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsNews and TrendsOwnershipSEC FilingsShort Interest About Drugs Made In America Acquisition Stock (NASDAQ:DMAA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get DMAA alerts:Sign Up Key Stats Today's Range$10.91▼$10.9150-Day Range$10.75▼$10.9452-Week Range$10.31▼$10.91Volume1,035 shsAverage Volume72,639 shsMarket Capitalization$264.77 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Drugs Made In America Acquisition Corp. is a special purpose acquisition company formed to pursue a merger, asset acquisition, or similar business combination. It does not operate a pharmaceutical business or manufacture drugs itself.The company’s stated focus was on identifying a business in the pharmaceutical industry, particularly one connected with drug manufacturing in the United States. Its activities were centered on seeking a suitable acquisition or merger candidate.AI Generated. May Contain Errors. Read More Drugs Made In America Acquisition Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks14th Percentile Overall ScoreDMAA MarketRank™: 0.722709998685 of 5 starsDrugs Made In America Acquisition scored higher than 14% of companies evaluated by MarketBeat, and ranked 544th out of 597 stocks in the technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingDrugs Made In America Acquisition has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageDrugs Made In America Acquisition has only been the subject of 1 research reports in the past 90 days.Read more about Drugs Made In America Acquisition's stock forecast and price target. Earnings and ValuationN/AProj. Earnings GrowthN/A Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.36% of the float of Drugs Made In America Acquisition has been sold short.Short Interest Ratio / Days to CoverDrugs Made In America Acquisition has a short interest ratio ("days to cover") of 4.95.Change versus previous monthShort interest in Drugs Made In America Acquisition has recently decreased by 4.00%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDrugs Made In America Acquisition does not currently pay a dividend.Dividend GrowthDrugs Made In America Acquisition does not have a long track record of dividend growth. News and Social Media3.0 / 5News SentimentN/A News SentimentDrugs Made In America Acquisition has a news sentiment score of 1.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Technology companies.News Coverage This WeekMarketBeat has tracked 1 news article for Drugs Made In America Acquisition this week, compared to 1 article on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Drugs Made In America Acquisition insiders have not sold or bought any company stock.Percentage Held by Insiders0.90% of the stock of Drugs Made In America Acquisition is held by insiders.Percentage Held by InstitutionsDrugs Made In America Acquisition has minimal institutional ownership at this time.Read more about Drugs Made In America Acquisition's insider trading history. Receive DMAA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Drugs Made In America Acquisition and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DMAA Stock News HeadlinesDrugs Made In America Acquisition (DMAA)October 25, 2026 | ru.investing.comSEC-deponeringenOctober 22, 2026 | nl.investing.comEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th. This free pick names the public company collecting on every unit.November 12 at 1:00 AM | Behind the Markets (Ad)Drugs Made In America revises PAGC merger termsOctober 21, 2026 | tipranks.comDMII - Drugs Made In America Acquisition II Corp.October 6, 2026 | seekingalpha.comDrugs Made In America Restructures Merger with PAGCSeptember 14, 2026 | tipranks.comDrugs Made In America Acquisition Corp. (DMAA)August 12, 2026 | finance.yahoo.comDrugs Made In America amends merger agreement termsJuly 20, 2026 | tipranks.comSee More Headlines DMAA Stock Analysis - Frequently Asked Questions How have DMAA shares performed this year? Drugs Made In America Acquisition's stock was trading at $10.3742 on January 1st, 2026. Since then, DMAA shares have increased by 5.1% and is now trading at $10.9030. How were Drugs Made In America Acquisition's earnings last quarter? Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) issued its quarterly earnings results on Friday, August, 14th. The company reported $0.06 earnings per share (EPS) for the quarter. Who are Drugs Made In America Acquisition's major shareholders? Drugs Made In America Acquisition's top institutional shareholders include First Trust Capital Management L.P. (3.24%). How do I buy shares of Drugs Made In America Acquisition? Shares of DMAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/14/2026Today11/12/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 DMAA's financial health is in the Green zone, according to TradeSmith. DMAA has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorTechnology Industry Software Sub-IndustryApplication Software Current SymbolNASDAQ:DMAA CIK2028614 Webdmaacorp.com Phone(646) 726-7074FaxN/AEmployees2Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares24,280,000Free Float24,059,000Market Cap$264.77 million OptionableN/A Beta0.01 The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:DMAA) was last updated on 11/12/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredTrump compared today's market to 1929President Trump warned of a 1929-style depression if Democrats won control of Congress. On November 3, they di...USA Capital Gold | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredDemocrats can stall every bill. They can’t stop this Trump order.The U.S. owns 8,133 tonnes of gold, still valued on the books at $42.22 an ounce. That price was set in 1973 a...Priority Gold | SponsoredA Bill Would Reprice America's Gold at Market ValueThe US government still values its gold at $42 an ounce, a price Congress set in 1973. Gold trades above $4,00...Concord Gold Capital | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Drugs Made In America Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Drugs Made In America Acquisition With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
